While the Trump administration targets COVID-19-related research, a new report from the ECDC shows the benefits of ...

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

The report points out that many health effects of long COVID, such as post-exertional malaise and chronic fatigue, cognitive ...

The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months ...

As public health systems strain and families like Jennifer’s wait for solutions, scientists at Johns Hopkins are working ...

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.

The FDA announced it will limit access to Covid-19 vaccines going forward to people 65 and older and others at high risk of ...

Long COVID—clinically known as post-acute sequelae of SARS-CoV-2 infection (PASC)—is a life-altering condition that affects more than 400 million people worldwide. Symptoms can persist for months or ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.